001     140686
005     20240321220845.0
024 7 _ |a 10.3233/JAD-181088
|2 doi
024 7 _ |a pmid:30909232
|2 pmid
024 7 _ |a 1387-2877
|2 ISSN
024 7 _ |a 1875-8908
|2 ISSN
024 7 _ |a altmetric:58068069
|2 altmetric
037 _ _ |a DZNE-2020-07008
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Alexopoulos, Panagiotis
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer's Disease with Dementia.
260 _ _ |a Amsterdam
|c 2019
|b IOS Press
264 _ 1 |3 print
|2 Crossref
|b IOS Press
|c 2019-05-07
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1710935708_2067
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Cost- and time-effective markers of Alzheimer’s disease (AD), reliable and feasible at the population level are urgently needed. Soluble amyloid-β protein precursor β (sAβPPβ) in plasma has attracted scientific attention as a potential AD biomarker candidate. Here we report that plasma sAβPPβ levels in patients with AD dementia and typical for AD cerebrospinal fluid (CSF) biomarker profiles (N = 33) are significantly lower (p < 0.01) than those of cognitively healthy elderly individuals without AD (N = 39), while CSF sAβPPβ levels did not differ between the studied groups. This provides further evidence for the potential of sAβPPβ in plasma as an AD biomarker candidate.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Alzheimer Disease: blood
|2 MeSH
650 _ 2 |a Alzheimer Disease: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Alzheimer Disease: diagnosis
|2 MeSH
650 _ 2 |a Amyloid beta-Protein Precursor: blood
|2 MeSH
650 _ 2 |a Amyloid beta-Protein Precursor: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Biomarkers: blood
|2 MeSH
650 _ 2 |a Biomarkers: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Dementia: blood
|2 MeSH
650 _ 2 |a Dementia: diagnosis
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a tau Proteins: cerebrospinal fluid
|2 MeSH
700 1 _ |a Thierjung, Nathalie
|b 1
700 1 _ |a Economou, Polychronis
|b 2
700 1 _ |a Werle, Lukas
|b 3
700 1 _ |a Buhl, Felix
|b 4
700 1 _ |a Kagerbauer, Simone
|b 5
700 1 _ |a Papanastasiou, Anastasios D
|b 6
700 1 _ |a Grimmer, Timo
|b 7
700 1 _ |a Gourzis, Philippos
|b 8
700 1 _ |a Berthele, Achim
|b 9
700 1 _ |a Hemmer, Bernhard
|b 10
700 1 _ |a Kübler, Hubert
|b 11
700 1 _ |a Martin, Jan
|b 12
700 1 _ |a Politis, Antonios
|b 13
700 1 _ |a Perneczky, Robert
|0 P:(DE-2719)2812234
|b 14
|e Last author
|u dzne
773 1 8 |a 10.3233/jad-181088
|b : IOS Press, 2019-05-07
|n 1
|p 83-90
|3 journal-article
|2 Crossref
|t Journal of Alzheimer's Disease
|v 69
|y 2019
|x 1387-2877
773 _ _ |a 10.3233/JAD-181088
|g Vol. 69, no. 1, p. 83 - 90
|0 PERI:(DE-600)2070772-1
|n 1
|q 69:1<83 - 90
|p 83-90
|t Journal of Alzheimer's disease
|v 69
|y 2019
|x 1387-2877
856 4 _ |u https://pub.dzne.de/record/140686/files/DZNE-2020-07008_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/140686/files/DZNE-2020-07008_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:140686
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2812234
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-18
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J ALZHEIMERS DIS : 2021
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-18
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-18
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-18
920 1 _ |0 I:(DE-2719)1111016
|k AG Levin
|l Clinical Neurodegeneration
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1111016
980 _ _ |a UNRESTRICTED
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.22628
|2 Crossref
|o 10.1002/ana.22628
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1474-4422(14)70090-0
|2 Crossref
|o 10.1016/S1474-4422(14)70090-0
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2011.03.005
|2 Crossref
|o 10.1016/j.jalz.2011.03.005
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2018.02.018
|2 Crossref
|o 10.1016/j.jalz.2018.02.018
999 C 5 |9 -- missing cx lookup --
|a 10.1007/978-1-4939-7674-4_6
|2 Crossref
|o 10.1007/978-1-4939-7674-4_6
999 C 5 |9 -- missing cx lookup --
|a 10.1159/000488481
|2 Crossref
|o 10.1159/000488481
999 C 5 |9 -- missing cx lookup --
|a 10.3233/ADR-170013
|2 Crossref
|o 10.3233/ADR-170013
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1474-4422(16)30040-0
|2 Crossref
|o 10.1016/S1474-4422(16)30040-0
999 C 5 |y 2017
|2 Crossref
|o Ritchie 2017
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awv181
|2 Crossref
|o 10.1093/brain/awv181
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-121549
|2 Crossref
|o 10.3233/JAD-121549
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.molmed.2013.10.001
|2 Crossref
|o 10.1016/j.molmed.2013.10.001
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2016.09.014
|2 Crossref
|o 10.1016/j.jalz.2016.09.014
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archneurol.2011.1841
|2 Crossref
|o 10.1001/archneurol.2011.1841
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1474-4422(16)00070-3
|2 Crossref
|o 10.1016/S1474-4422(16)00070-3
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature25456
|2 Crossref
|o 10.1038/nature25456
999 C 5 |9 -- missing cx lookup --
|a 10.15252/emmm.201708763
|2 Crossref
|o 10.15252/emmm.201708763
999 C 5 |9 -- missing cx lookup --
|a 10.1038/tp.2013.11
|2 Crossref
|o 10.1038/tp.2013.11
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.brainres.2013.03.019
|2 Crossref
|o 10.1016/j.brainres.2013.03.019
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s12017-012-8171-4
|2 Crossref
|o 10.1007/s12017-012-8171-4
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-2011-110857
|2 Crossref
|o 10.3233/JAD-2011-110857
999 C 5 |y 2011
|2 Crossref
|o Mulugeta 2011
999 C 5 |9 -- missing cx lookup --
|a 10.1111/ncn3.12195
|2 Crossref
|o 10.1111/ncn3.12195
999 C 5 |9 -- missing cx lookup --
|a 10.1186/s40364-017-0108-5
|2 Crossref
|o 10.1186/s40364-017-0108-5
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2013.09.006
|2 Crossref
|o 10.1016/j.jalz.2013.09.006
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00406-017-0815-9
|2 Crossref
|o 10.1007/s00406-017-0815-9
999 C 5 |y 2018
|2 Crossref
|o Illán-Gala 2018
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00406-015-0628-7
|2 Crossref
|o 10.1007/s00406-015-0628-7
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-122329
|2 Crossref
|o 10.3233/JAD-122329
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1471-4159.1993.tb09823.x
|2 Crossref
|o 10.1111/j.1471-4159.1993.tb09823.x
999 C 5 |9 -- missing cx lookup --
|a 10.3109/13506120009146438
|2 Crossref
|o 10.3109/13506120009146438
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.52.8.1555
|2 Crossref
|o 10.1212/WNL.52.8.1555
999 C 5 |9 -- missing cx lookup --
|a 10.1007/978-1-4939-7674-4_12
|2 Crossref
|o 10.1007/978-1-4939-7674-4_12
999 C 5 |y 2015
|2 Crossref
|t Lösliches Amyloidvorläuferprotein Beta als Biomarker für die Alzheimer-Krankheit
|o Werle Lösliches Amyloidvorläuferprotein Beta als Biomarker für die Alzheimer-Krankheit 2015
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-160176
|2 Crossref
|o 10.3233/JAD-160176
999 C 5 |9 -- missing cx lookup --
|a 10.1186/s13195-018-0411-x
|2 Crossref
|o 10.1186/s13195-018-0411-x
999 C 5 |9 -- missing cx lookup --
|a 10.1016/0140-6736(91)92823-K
|2 Crossref
|o 10.1016/0140-6736(91)92823-K
999 C 5 |9 -- missing cx lookup --
|a 10.2307/1907382
|2 Crossref
|o 10.2307/1907382
999 C 5 |9 -- missing cx lookup --
|a 10.1002/jnr.22618
|2 Crossref
|o 10.1002/jnr.22618
999 C 5 |2 Crossref
|o
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nrneurol.2017.111
|2 Crossref
|o 10.1038/nrneurol.2017.111
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s12035-014-8694-9
|2 Crossref
|o 10.1007/s12035-014-8694-9
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archneur.57.1.100
|2 Crossref
|o 10.1001/archneur.57.1.100
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.1197623
|2 Crossref
|o 10.1126/science.1197623
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-170784
|2 Crossref
|o 10.3233/JAD-170784
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jns.2018.06.006
|2 Crossref
|o 10.1016/j.jns.2018.06.006


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21